Ginger efficacy in patients uncontrolled on standard moderate asthma treatment

Not Applicable

• Conditions: Asthma.; Moderate asthma

• Registration Number: IRCT201010194970N1
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

40 consenting non-smoking patients aged between 16 and 70 years with a documented positive bronchodilator reversibility test with = 15% improvement in FEV1 from 15 to 30 minutes after inhalation of at least 200 µg of salbutamol are enrolled in the 10-week, randomized controlled cross over study.
Exclusion criteria for the study are: emergency treatment for an asthma exacerbation within one month, COPD, upper airway infections in the last three weeks, hospitalization for asthma in the three months previous to enrolment, treatment with antihistamines, anticholinergics, theophyline and chromones, oral corticosteroids and ß2 agonists, presence of autoimmune, cardiac, hepatic or renal disorders, malabsorption, drug-addiction, pregnancy and lactation.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Spirometric tests. Timepoint: Weeks 1, 3, 5, 6, 8, 10. Method of measurement: Spirometry apparatus.;Immunologic tests. Timepoint: Weeks 1, 3, 5, 6, 8, 10. Method of measurement: laboratorial evaluation of IgE and sputum eosinophil.;Condition of asthma control. Timepoint: Weeks 1, 3, 5, 6, 8, 10. Method of measurement: Clinical memoir, physical examination, completion of asthma control questionnaires.

Secondary Outcome Measures

Name	Time	Method
Side effect of drugs. Timepoint: weeks 1, 3, 5, 6, 8, 10. Method of measurement: Clinical memoir, Physical examination.